Ampvolts Fund Raise of ₹48 Cr

Ampvolts Board Meeting Date

Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.

Ampvolts Other Announcement

Ampvolts Ltd has submitted its quarterly shareholding pattern statement for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).

Ampvolts Management Change

Ampvolts Limited has appointed M/s. MYSP & Associates LLP as its Statutory Auditor for a 60-month term. The firm brings over 34 years of experience in audit and consultancy.

Execution

60 months

Ampvolts Other Announcement

Ampvolts Limited has appointed M/s. MYSP & Associates LLP as Statutory Auditors for a five-year term. The appointment is effective from the 27th Annual General Meeting.

Execution

5 years

Ampvolts Annual General Meeting

Ampvolts Limited held its 27th Annual General Meeting on September 30, 2026. The meeting covered standard agenda items, including financial statement adoption and statutory auditor appointment.

Ampvolts Annual Report

Ampvolts Limited has filed its Annual Report for the financial year 2025-26, including the notice for its 27th Annual General Meeting.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.